Egrifta (eh-GRIF-tuh, tesamorelin), the first drug to treat abdominal fat deposits caused by HIV meds
You'll hear about Egrifta (eh-GRIF-tuh, tesamorelin), the first drug to treat abdominal fat deposits caused by HIV meds.
This lipodystrophy can be distressing to patients...decrease adherence to HIV meds...and might increase cardiovascular risk.
Egrifta is a human growth hormone releasing factor that's injected subcutaneously once daily.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote